Given with what's going on with Vioxx and Cellebrex, this company is very important as the FDA will be asking for lengthier testing on these areas. Looks on this as a fabulous growth story.

A re-structuring story. Very successful management.

A consolidating industry. Benefiting tremendously from technology and geographical expansion.

New entity called spoken audio content which downloads newspaper, textbooks, radio programming. A really good growth story.

Had a big correction so there is a buying opportunity. A story thats growing by about 20% a year. Trading at 15 X earnings.